High Portfolio Occupancy and Lease Duration
Portfolio occupancy near historical highs at 97% and a weighted average lease term of roughly 10 years, supporting stable and predictable cash flows.
Quarterly and Full-Year Core FFO Growth
Core FFO per share grew nearly 6% year-over-year in Q4 to $0.77 and grew nearly 3% year-over-year for the full year to $2.99, demonstrating execution on the stated growth target.
2026 Core FFO Guidance
Maintained full-year 2026 core FFO per share guidance of $3.05 to $3.12, implying approximately 3% core FFO per share growth at the midpoint (above the stated 2%-3% target range midpoint).
Strong Cash Available for Distribution
Cash available for distribution of $29.1 million in Q4 and $118.0 million for the full year, reflecting steady operational performance.
Accretive Virginia Acquisition
Completed a three-asset acquisition in Virginia for $44.5 million (~298,000 RSF) with the Commonwealth of Virginia as the primary tenant, 2.5% annual rent escalations, a weighted average lease term of 7.5 years, and a going-in cash cap rate of ~11%; transaction described as immediately accretive to returns.
Development Pipeline Progress and Deliveries
Major development milestones include delivery of FDA Atlanta (completed Dec 15, 2025) with $138.1M in lump-sum reimbursements received as of 12/31/2025 (plus an additional $12.6M received subsequently and ~ $3M expected soon). Broke ground on State Crime Lab in Fort Myers (delivery targeted 2026); Flagstaff U.S. Courthouse under construction (delivery 2027); Medford U.S. Courthouse construction commenced (delivery 2027). Combined upcoming projects represent ~200,000 rentable square feet of high-credit cash flows.
Strong Renewal Execution
Since IPO, 38 leases renewed totaling ~2.6 million RSF; of these, 27 renewals required no tenant improvement (TI) or TI completed, 11 with pending TI. Excluding certain assets, average rent spread on renewals was ~14% with a weighted average renewal term of 15.7 years.
Pipeline and Acquisition Opportunity Set
Management cites an active acquisition and development pipeline (cited as approximately $1.0 billion) and a larger pipeline referenced in discussion, with the team focused on sourcing assets that provide spreads in excess of cost of capital.
Balance Sheet and Leverage Management
Cash leverage (net debt to annualized quarterly EBITDA) stands at 7.5x and management expects reimbursements and execution to drive improvement toward a medium-term objective of ~6x, supporting lower funding costs and potential investment grade positioning.
Disciplined Capital Allocation and Growth Philosophy
Company reiterates a repeatable strategy of 2%-3% core FFO per share annual growth, prioritizing mission-critical, high-credit tenancy, disciplined underwriting (targeting returns >100 bps above WACC), and selective development/acquisition to balance durability and growth.